| Cat. No. |
Product Name |
Information |
| PC-20885 |
JET-209
CBP/p300 PROTAC
|
JET-209 (JET209) is a potent, selective PROTAC degrader of CBP/p300 based on GNE-207 with DC50 of 0.05 nM for CBP and 0.2 nM for p300, Dmax >95% for both proteins in the RS4;11 leukemia cell line. |
| PC-20755 |
(R)-SL18
ANXA3 degrader
|
(R)-SL18 is a first-in-class, selective Annexin A3 (ANXA3) degrader, induces degradation of ANXA3 in MDA-MB-231 cells with DC50 value of 3.17 uM. |
| PC-20694 |
FHD-609
BRD9 PROTAC
|
FHD-609 (FHD609) is a potent and selective heterobifunctional protein degrader (PROTAC) of BRD9, a subunit of non-canonical BAF complex, strong anti-tumor efficacy in a subtype of AML. |
| PC-20693 |
KT-474
IRAK4 PROTAC
|
KT-474 (SAR444656, KYM-001) is a potent, selective, and orally bioavailable heterobifunctional IRAK4 PROTAC degrader with DC50 of 2 nM in OCI-Ly10 cells, IC50 of 41 nM. |
| PC-20684 |
BSJ-04-146
FAK PROTAC
|
BSJ-04-146 is a potent, selective FAK PROTAC (IC50=26 nM), induces potent and durable FAK degradation in pancreatic and breast cancer cell lines at 10 nM. |
| PC-20680 |
MRT-2359
GSPT1 degrader
|
MRT-2359 (MRT2359) is a potent, selective and orally bioavailable GSPT1-directed molecular glue degrader with DC50 of 5 nM in CAL51 cell line (Dmax=100%). |
| PC-20665 |
ARV-766
AR PROTAC
|
ARV-776 (Luxdegalutamide, ARV776) is potent, orally bioavailable PROTAC androgen receptor (AR) degrader that degrades not only wild-type AR but also clinically relevant AR LBD mutants, including the most prevalent AR L702H, H875Y, and T878A mutations. |
| PC-20593 |
CFT1946
mutant BRAF PROTAC
|
CFT1946 (CFT-1946) is a potent, selective CRBN-based PROTAC degrader of mutant BRAF, selectively degrades BRAF V600E (Class I), G469A (Class II), G466V (Class III) mutations and the p61-BRAFV600E splice variant, but not WT BRAF and CRAF. |
| PC-20565 |
CP5V
Cdc20 PROTAC
|
CP5V (apcin-A-PEG5-VHL Ligand 1) is an efficient, selective Cdc20 PROTAC with DC50 of 1.6 uM in both MCF7 and MDA-MB-231 cells, induces mitotic inhibition and suppresses cancer cell proliferation. |
| PC-20560 |
NX-2127
BTK PROTAC
|
NX-2127 (NX2127) is a hetero-bifunctional, orally active PROTAC that induces the degradation of BTK and IKZF3 ubiquitination and proteasomal degradation in cells through recruitment of cereblon (CRBN). |
| PC-20466 |
BSJ-05-037
ITK PROTAC
|
BSJ-05-037 is a potent and selective heterobifunctional degrader of ITK with DC50 of 17.6-41.8 nM in TCL lines DERL-2 and Hut78. |
| PC-20464 |
BI 1810284
SMARCA2 PROTAC
|
BI 1810284 (ACBI2, BI 01810284) is a potent, selective and orally bioavailable VHL-recruiting PROTAC degrader of SMARCA2 (DC50=1 nM in RKO cells), 30-fold selectivity over SMARCA4. |
